What are the treatment options for cluster headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Cluster Headaches

For the treatment of cluster headaches, subcutaneous sumatriptan (6 mg) or high-flow oxygen therapy (100% oxygen at 12 L/min for 15 minutes) are recommended as first-line abortive treatments, while galcanezumab is suggested for prevention of episodic cluster headache. 1

Abortive (Acute) Treatment Options

First-Line Treatments:

  1. Subcutaneous Sumatriptan (6 mg)

    • Recommended with a weak recommendation for short-term treatment 1
    • Provides rapid relief within 10-15 minutes in approximately 74% of attacks compared to 26% with placebo 2
    • FDA-approved data shows 74% of patients achieve pain relief within 15 minutes 3
    • Particularly effective for severe attacks or those with significant nausea/vomiting
  2. High-Flow Oxygen Therapy

    • 100% oxygen at 12 L/min via face mask for 15 minutes 4
    • Recommended with a weak recommendation 1
    • Effective in 78% of attacks versus 20% with placebo 4
    • No significant adverse events reported 4
    • Non-pharmacological option with minimal side effects
  3. Intranasal Zolmitriptan (10 mg)

    • Alternative to subcutaneous sumatriptan 1
    • Less rapid onset than subcutaneous sumatriptan but still effective

Second-Line Treatments:

  1. Noninvasive Vagus Nerve Stimulation
    • Recommended with a weak recommendation for episodic cluster headache 1
    • Not effective for chronic cluster headache 5
    • Option for patients who cannot tolerate or have contraindications to first-line treatments

Preventive Treatment Options

First-Line Prevention:

  1. Galcanezumab
    • Recommended with a weak recommendation for episodic cluster headache 1
    • Not recommended for chronic cluster headache (weak against recommendation) 1
    • CGRP monoclonal antibody that has shown efficacy specifically in episodic cluster headache

Other Preventive Options:

  1. Verapamil

    • Insufficient evidence to make a firm recommendation 1
    • However, European guidelines recommend verapamil at a daily dose of at least 240 mg 5
    • Requires ECG monitoring due to potential cardiac effects
  2. Corticosteroids (Bridge Therapy)

    • Used as short-term "bridge" therapy until other preventive medications take effect 6
    • Can be administered orally or as suboccipital injections 6
    • Typically used for 5-7 days at doses of at least 100 mg prednisone or equivalent 5
  3. Lithium

    • Alternative preventive option, particularly for chronic cluster headache 6
    • Requires blood level monitoring and has potential side effects

Treatment Algorithm

  1. For Acute Attack:

    • First attempt: High-flow oxygen (100% at 12 L/min via face mask for 15 minutes)
    • If oxygen unavailable or ineffective: Subcutaneous sumatriptan 6 mg
    • Alternative if above not tolerated: Intranasal zolmitriptan 10 mg
  2. For Prevention:

    • For episodic cluster headache: Galcanezumab
    • For chronic cluster headache: Consider verapamil (with ECG monitoring)
    • Bridge therapy: Short course of corticosteroids while initiating preventive treatment

Important Considerations

  • Avoid medication overuse: Limit acute medications to prevent medication overuse headache
  • Avoid opioids and butalbital: These are not recommended for cluster headache treatment 7
  • Treatment timing: Begin treatment as soon as possible after headache onset for maximum effectiveness 7
  • Monitoring: Regular follow-up to assess treatment efficacy and adjust as needed

Pitfalls and Caveats

  • Misdiagnosis: Ensure proper diagnosis of cluster headache versus other primary headache disorders
  • Cardiac risk with triptans: Contraindicated in patients with coronary artery disease, uncontrolled hypertension, or history of stroke
  • Oxygen delivery: Ensure proper flow rate (12 L/min minimum) and delivery method (non-rebreather mask) for oxygen therapy
  • Medication overuse: Monitor frequency of acute medication use to prevent medication overuse headache
  • Treatment resistance: Some patients with chronic cluster headache may be refractory to standard treatments and require referral to headache specialists

By following this treatment approach, most patients with cluster headache can achieve significant relief from this extremely painful condition, improving their quality of life and reducing disability.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of cluster headache: clinical trials, design and results.

Cephalalgia : an international journal of headache, 1995

Research

Management of cluster headache: Treatments and their mechanisms.

Cephalalgia : an international journal of headache, 2023

Guideline

Headache Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.